HawkEye 360 Awarded Multi-Year Contract to Enhance Indian Ocean Region Maritime Domain Awareness
HERNDON, Va., July 23, 2026 /PRNewswire/ — HawkEye 360, Inc. (NYSE: HAWK) the global leader in signals intelligence data and analytics, today announced it... Read more.
TAT Technologies to Report Second Quarter Results on August 5 and Host Webcast
CHARLOTTE, N.C., July 23, 2026 /PRNewswire/ — TAT Technologies Ltd. (NASDAQ: TATT, TASE: TATT), a leading supplier of products and services for the commercial... Read more.
PUBLIC TRUST IN HEALTH INNOVATION IS SHAPED MORE BY MINDSET THAN DEMOGRAPHICS, DNV RESEARCH FINDS
OSLO, Norway, July 23, 2026 /PRNewswire/ — Public trust in health innovation may be less predictable than healthcare organizations assume, according to new... Read more.
STANDEX DECLARES 248th CONSECUTIVE QUARTERLY DIVIDEND
SALEM, N.H., July 23, 2026 /PRNewswire/ — Standex International Corporation (NYSE: SXI) today announced that its Board of Directors has declared a quarterly... Read more.
Medgene offers first-ever cattle vaccine to address Theileria
BROOKINGS, S.D., July 23, 2026 /PRNewswire/ — A new vaccine addressing a globally prevalent tick-borne pathogen is now available. Medgene, a South Dakota-based... Read more.
Equable Institute Analysis: U.S. Public Pensions Reach Best Funded Status Since 2009 – But Remain $1.13 Trillion Short
Four straight years of above-target investment returns have lifted the national funded ratio to 85%, according to Equable Institute’s 7th annual State of Pensions... Read more.
Disrupting Legal Access: Why Small Law Firms Are Drowning in Admin
Saumya Banker says the legal industry is still burying lawyers under billing guesswork, deadline-driven workflows, and admin work clients should never have to subsidize.... Read more.
SphingoTec CEO to Attend ADLM 2026
HENNIGSDORF, Germany, July 23, 2026 /PRNewswire/ — SphingoTec GmbH announces that its Chief Executive Officer, Deborah Bergmann, will attend the ADLM 2026... Read more.
New Unlock Survey: Homeowner Parents Face a Dual Caregiving Crisis
41% are supporting both their children and their parents at the same time – and most aren’t clear how the home equity they’ve built could help. TEMPE,... Read more.
Accord BioPharma Announces Commercial Availability of Denosumab Biosimilars OSVYRTI® (denosumab-desu) and JUBEREQ® (denosumab-desu)
Biosimilars strengthen access to treatment for certain bone health conditions. RALEIGH, N.C., July 23, 2026 /PRNewswire/ — Accord BioPharma, Inc., the U.S.... Read more.